Keyphrases
Disease Severity
100%
Relation to Disease
100%
Locus Coeruleus
100%
Progressive Supranuclear Palsy
100%
Neuronal Loss
22%
Clinical Severity
22%
Clinical Heterogeneity
22%
Noradrenergic
22%
Positive Inclusion
22%
Tau Pathology
22%
Richardson's Syndrome
22%
Rating Scales
11%
Immunohistochemistry
11%
Clinical Assessment
11%
Cognitive Function
11%
Pharmacological Treatment
11%
Noradrenaline
11%
Disease Duration
11%
Patient Relatives
11%
Clinical Diagnosis
11%
Low-field Magnetic Resonance Imaging
11%
Arousal
11%
Physiological Function
11%
Neurodegeneration
11%
Autonomic Control
11%
Negatively Associated
11%
Structural Integrity
11%
Postmortem Tissue
11%
Adaptive Behavior
11%
Clinical Expression
11%
Tau Protein
11%
Phosphorylated tau
11%
Pigment Cell
11%
Experimental Medicine
11%
Clinical Death
11%
Antemortem
11%
Noradrenergic Neurons
11%
Controlling Behavior
11%
Medicine and Dentistry
Disease Severity
100%
Progressive Supranuclear Palsy
100%
Locus Coeruleus
100%
Tau
66%
Disease
11%
Clinical Assessment
11%
Drug Therapy
11%
Biological Marker
11%
Medicine
11%
Rating Scale
11%
Disease Duration
11%
Immunohistochemistry
11%
High Field Magnetic Resonance Imaging
11%
Neurodegeneration
11%
Cognition
11%
Noradrenalin
11%
K-Complex
11%
Adaptive Behavior
11%
Tau Protein
11%
Neuroscience
Locus Coeruleus
100%
Progressive Supranuclear Palsy
100%
Clinical Assessment
11%
In Vivo
11%
Behavior (Neuroscience)
11%
Cognitive Function
11%
Immunohistochemistry
11%
Norepinephrine
11%
Neurodegeneration
11%
Tau Protein
11%
High Field Magnetic Resonance Imaging
11%